Cargando…

SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry

BACKGROUND: Small-molecule compounds that inhibit human immunodeficiency virus type 1 (HIV-1) infection can be used not only as drug candidates, but also as reagents to dissect the life cycle of the virus. Thus, it is desirable to have an arsenal of such compounds that inhibit HIV-1 infection by var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Ru, Zhang, Xing-Jie, Li, Yan-Li, Liu, Jing-Ping, Zhang, Hong-Bin, Xiao, Wei-Lie, Pu, Jian-Xin, Sun, Han-Dong, Zheng, Yong-Tang, Liu, Li-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667461/ https://www.ncbi.nlm.nih.gov/pubmed/26630969 http://dx.doi.org/10.1186/s12866-015-0605-3

Ejemplares similares

SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure
por: Zhang, Xing-Jie, et al.
Publicado: (2018)

Genomic and probiotic characterization of SJP-SNU strain of Pichia kudriavzevii
por: Hong, Seung-Min, et al.
Publicado: (2018)

A Comparison of the Antinociceptive Properties of SJP-005 and Morphine in Rats
por: Verster, Joris C, et al.
Publicado: (2021)

Functional observation after morphine withdrawal: effects of SJP-005
por: Verster, Joris C., et al.
Publicado: (2021)

The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study
por: Verster, Joris C, et al.
Publicado: (2020)

HIV entry blocked by maraviroc can cause an overestimation of viral load
por: Sloan, RD, et al.
Publicado: (2010)

Genome sequence of a high agarase-producing strain Flammeovirga sp. SJP92
por: Dong, Qi, et al.
Publicado: (2017)

rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway
por: Chen, Liuting, et al.
Publicado: (2019)

Filovirus Tropism: Cellular Molecules for Viral Entry
por: Takada, Ayato
Publicado: (2012)

Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies
por: Kiani, Pantea, et al.
Publicado: (2022)

Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer
por: Jeon, Myeongjin, et al.
Publicado: (2023)

Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture
por: Coburn, Glen A., et al.
Publicado: (2012)

Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure
por: Nieto-Garai, Jon Ander, et al.
Publicado: (2018)

Entry Inhibitors: Efficient Means to Block Viral Infection
por: Pattnaik, Gourab Prasad, et al.
Publicado: (2020)

HIV Nuclear Entry: Clearing the Fog
por: Shah, Vaibhav B., et al.
Publicado: (2010)

The prevention of side effects after vaccination against influenza: four case studies examining the efficacy of SJP-003
por: Kiani, P., et al.
Publicado: (2022)

The efficacy of a combination of naproxen and fexofenadine (SJP − 002) to inhibit the symptoms that are associated with viral upper respiratory tract infection: Four case reports of individuals with common cold
por: Išerić, Emina, et al.
Publicado: (2023)

A DNA aptamer efficiently inhibits the infectivity of Bovine herpesvirus 1 by blocking viral entry
por: Xu, Jian, et al.
Publicado: (2017)

Identification of a clinical compound losmapimod that blocks Lassa virus entry
por: Zhang, Xiaoyu, et al.
Publicado: (2019)

Single-molecule 3D imaging of HIV cellular entry by liquid-phase electron tomography
por: Kong, Lingli, et al.
Publicado: (2022)

The Role of Capsid in HIV-1 Nuclear Entry
por: Guedán, Anabel, et al.
Publicado: (2021)

Antiviral and virucidal activities of lycorine on duck tembusu virus in vitro by blocking viral internalization and entry
por: Lv, Xuan, et al.
Publicado: (2021)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator
por: Wang, Xiaohuan, et al.
Publicado: (2019)

HIV, cyclophilins and nuclear entry: going under the radar
por: Towers, Greg
Publicado: (2011)

Dynamic Oligomerization of Integrase Orchestrates HIV Nuclear Entry
por: Borrenberghs, Doortje, et al.
Publicado: (2016)

Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry
por: Dabrell, Shaneek Natoya, et al.
Publicado: (2023)

PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms
por: Huskens, Dana, et al.
Publicado: (2010)

Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice
por: Pan, Hudan, et al.
Publicado: (2023)

The Efficacy of the Combination of Naproxen and Fexofenadine (SJP-003) to Prevent or Reduce Side Effects of Receiving Multiple Travel Vaccines: A Case Report
por: Kiani, Pantea, et al.
Publicado: (2022)

Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist
por: Courter, Joel R., et al.
Publicado: (2014)

Viral and Cellular Requirements for the Nuclear Entry of Retroviral Preintegration Nucleoprotein Complexes
por: Matreyek, Kenneth A., et al.
Publicado: (2013)

HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration
por: Guedán, Anabel, et al.
Publicado: (2021)

A novel small-molecule inhibitor of HIV-1 entry
por: Heredia, Alonso, et al.
Publicado: (2015)

Penaeidins restrict white spot syndrome virus infection by antagonizing the envelope proteins to block viral entry
por: Xiao, Bang, et al.
Publicado: (2020)

HIV-1 capsid is involved in post-nuclear entry steps
por: Chen, Nan-Yu, et al.
Publicado: (2016)

Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes
por: Zhou, Xueyuan, et al.
Publicado: (2016)

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection
por: Dong, Wenjuan, et al.
Publicado: (2023)

The CH24H metabolite, 24HC, blocks viral entry by disrupting intracellular cholesterol homeostasis
por: Yuan, Yueming, et al.
Publicado: (2023)

Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammal
por: Pask, Andrew J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tinmb8drbeqp1217ul4nmtavqb